Ae. Frost et al., GIANT-CELL INTERSTITIAL PNEUMONITIS - DISEASE RECURRENCE IN THE TRANSPLANTED LUNG, The American review of respiratory disease, 148(5), 1993, pp. 1401-1404
Recurrence of the original disease in the transplanted organ is well r
eported in renal transplant recipients. There have been no previously
fully documented cases of recurrence of the original disease after lun
g transplantation. We report a patient who underwent single-lung trans
plant in 1990 for end-stage respiratory failure secondary to biopsy-pr
oved giant cell interstitial pneumonitis (GIP). There was no further i
ndustrial exposure. Surveillance bronchoscopies and biopsies post-tran
splant demonstrated eosinophils and giant cells in the bronchoalveolar
ravage of both lungs, and in biopsies of the transplanted organ. Two
years after successful transplantation the patient deteriorated and un
derwent open lung biopsy, which demonstrated not only bronchiolitis ob
literans but also the classic features of GIP. There was no evidence o
f inorganic particles in the transplanted lung. Autopsy confirmed the
presence of numerous giant cells characteristic of GIP with associated
fibrosis throughout the transplanted lung. Although tungsten and othe
r inorganic particles were again demonstrated in the native lung, ther
e was no evidence of tungsten particles in the transplanted lung. We b
elieve that this case documents recurrence of the original disease aft
er lung transplantation. The absence of unusual inorganic particles in
the transplanted lung in the face of the classic picture of GIP is hi
ghly suggestive of an autoimmune mechanism for this occupation-associa
ted disease. The appropriateness of transplant in the management of th
is lung disease should be reviewed further.